Press Releases

  • October 22, 2026

    CorWave Completes Enrollment in Feasibility Study and Presents First Clinical Data on Adaptive Support with its Wave Membrane LVAD

     

    • May 29, 2026

      CorWave Achieves Major Regulatory Milestone with ISO 13485 Certification Across its Entire Operations

       

      • March 31, 2026

      CorWave Strengthens Its Leadership Team with Two Key Appointments – Andreas Fleischli Appointed Chief Technology Officer and Daniel Lexcen Named Vice President Clinical & Scientific Affairs

       

      • September 29, 2025

      CorWave Announces Presentation of Late Breaking Results from its First-In-Human Implant at HFSA Annual Scientific Meeting

       

      • July 09, 2025

      World First: CorWave’s Undulating Membrane Heart Pump Implanted in First Patient

       

      • April 24, 2025

      CorWave Announces Successful Completion of 6-Month Chronic In Vivo Study, Paving the Way for Clinical Trial Initiation.

       

      • April 02, 2025

      CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production.

       

      • October 09, 2023

      CorWave Announces the Grand Opening of its Manufacturing Facility on the Banks of the Seine, Next to Paris.

       

      • June 20, 2023

      CorWave Announces Second Closing of Its Series C Funding at €61M To Finance Its First Industrial Deployment.

       

      • March 17, 2022

      CorWave To Set Up Its Manufacturing Facility and Expand To A New Site Next to Paris.

       

      • October 19, 2021

      CorWave Wins 2021 HealthTech Award.

       

      • September 21, 2021

      CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up.

       

      • June 14, 2021

      CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting.

       

      • April 27, 2021

      CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation.

       

      • February 08, 2021

      CorWave Joins the French Tech 120 Index, a Community That Brings Together the Top French Tech Scale-up Companies.

       

      • January 06, 2021

      CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor.

       

      • November 19, 2020

      CorWave Secures a €500,000 Grant From the Paris Region for Its Industrial Facilities.

       

      • July 21, 2020

      CorWave Awarded €2.5M From the European Commission Through the EIC Accelerator Program.

       

      • June 10, 2020

      CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting.

       

      • February 11, 2020

      CorWave Appoints Jim Schuermann as an Independent Director.

       

      • September 11, 2019

      CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device.

       

      • June 28, 2019

      CorWave To Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device.

       

      • July 10, 2018

      CorWave’s next-generation LVAD receives funding.

       

      • July 05, 2018

      Corwave Announces Issuance of US Patent Covering Its Implantable Left Ventricular Assist Device Leveraging the Wave Membrane Technology.

       

      • March 16, 2018

      CorWave scales up increasing its R&D capabilities and opening a pilot production unit at its new Clichy site.

       

      • March 15, 2018

      CorWave is pegged as a potential billion-euro company as part of “Future Unicorn” competition.

       

      • April 03, 2018

      CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support.

       

      • November 08, 2017

      CorWave Receives 2017 Deloitte ‘Technology Fast 50 Biotech of the Future’ Award of the Parisian Region.

       

      • November 04, 2016

      CorWave Raises $17.1 Million in Series B Financing.

       

      • July 22, 2016

      CorWave Awarded at the Worldwide Innovation Challenge.

       

      • December 08, 2015

      CorWave Presents Promising Early Results for Innovative Wave Membrane Blood Pump.